OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Incidence and management of the main serious adverse events reported after COVID ‐19 vaccination
Teresa Padilla‐Flores, Alicia Sampieri, Luis Vaca
Pharmacology Research & Perspectives (2024) Vol. 12, Iss. 3
Open Access | Times Cited: 9
Teresa Padilla‐Flores, Alicia Sampieri, Luis Vaca
Pharmacology Research & Perspectives (2024) Vol. 12, Iss. 3
Open Access | Times Cited: 9
Showing 9 citing articles:
Events supposedly attributable to vaccination or immunization of COVID-19 vaccines in Brazil: a cross-sectional study
Paloma Cristina Pimenta, Vitoria Gabriele Souza Geraldine, Túlio M. Lima, et al.
Deleted Journal (2025) Vol. 22, Iss. 1
Open Access
Paloma Cristina Pimenta, Vitoria Gabriele Souza Geraldine, Túlio M. Lima, et al.
Deleted Journal (2025) Vol. 22, Iss. 1
Open Access
A SARS-CoV-2 mucosal nanovaccine based on assembly of maltodextrin, STING agonist and polyethyleneimine
Yu Tian, Liang Hu, Qingrui Huang, et al.
International Journal of Biological Macromolecules (2025), pp. 139395-139395
Closed Access
Yu Tian, Liang Hu, Qingrui Huang, et al.
International Journal of Biological Macromolecules (2025), pp. 139395-139395
Closed Access
Nanotechnology Assisted Strategies to Tackle COVID and Long-COVID
Keshaw Ram Aadil, Khushboo Bhange, Gita D. Mishra, et al.
BioNanoScience (2025) Vol. 15, Iss. 2
Closed Access
Keshaw Ram Aadil, Khushboo Bhange, Gita D. Mishra, et al.
BioNanoScience (2025) Vol. 15, Iss. 2
Closed Access
COVID-19 Modified mRNA “Vaccines”: Lessons Learned from Clinical Trials, Mass Vaccination, and the Bio-Pharmaceutical Complex, Part 2
M. Nathaniel Mead, Stephanie Seneff, Jessica Rose, et al.
International Journal of Vaccine Theory Practice and Research (2024) Vol. 3, Iss. 2, pp. 1275-1344
Open Access | Times Cited: 2
M. Nathaniel Mead, Stephanie Seneff, Jessica Rose, et al.
International Journal of Vaccine Theory Practice and Research (2024) Vol. 3, Iss. 2, pp. 1275-1344
Open Access | Times Cited: 2
An improvement of the safety profile of SARS‐CoV‐2 vaccines is desirable
Josef Finsterer
Pharmacology Research & Perspectives (2024) Vol. 12, Iss. 5
Open Access
Josef Finsterer
Pharmacology Research & Perspectives (2024) Vol. 12, Iss. 5
Open Access
Safety of COVID-19 Vaccines among People with History of Allergy: A European Active Surveillance Study
Nicoletta Luxi, Francesco Ciccimarra, Chiara Bellitto, et al.
Vaccines (2024) Vol. 12, Iss. 9, pp. 1059-1059
Open Access
Nicoletta Luxi, Francesco Ciccimarra, Chiara Bellitto, et al.
Vaccines (2024) Vol. 12, Iss. 9, pp. 1059-1059
Open Access
Characteristics of Oral Adverse Effects following COVID-19 Vaccination and Similarities with Oral Symptoms in COVID-19 Patients: Taste and Saliva Secretory Disorders
Hironori Tsuchiya, Maki Mizogami
Medical Principles and Practice (2024), pp. 1-33
Open Access
Hironori Tsuchiya, Maki Mizogami
Medical Principles and Practice (2024), pp. 1-33
Open Access
Global burden of vaccine-associated cutaneous immune-related adverse events, 1968–2024: An international pharmacovigilance study
Jaehyeong Cho, Hyesu Jo, Damiano Pizzol, et al.
Life Cycle (2024) Vol. 4
Closed Access
Jaehyeong Cho, Hyesu Jo, Damiano Pizzol, et al.
Life Cycle (2024) Vol. 4
Closed Access
